-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Zymeworks, Raises Price Target to $55

Benzinga·08/26/2026 10:12:26
Listen to the news
HC Wainwright & Co. analyst Robert Burns maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $51 to $55.